EE200200146A - Loteprednooli ja antihistamiinsete ainete uudne kombinatsioon - Google Patents

Loteprednooli ja antihistamiinsete ainete uudne kombinatsioon

Info

Publication number
EE200200146A
EE200200146A EEP200200146A EEP200200146A EE200200146A EE 200200146 A EE200200146 A EE 200200146A EE P200200146 A EEP200200146 A EE P200200146A EE P200200146 A EEP200200146 A EE P200200146A EE 200200146 A EE200200146 A EE 200200146A
Authority
EE
Estonia
Prior art keywords
loteprednol
antihistamines
novel combination
novel
combination
Prior art date
Application number
EEP200200146A
Other languages
English (en)
Inventor
Szelenyi Istvan
Marx Degenhard
Heer Sabine
Engel J�rgen
Original Assignee
Viatris Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh & Co. Kg filed Critical Viatris Gmbh & Co. Kg
Publication of EE200200146A publication Critical patent/EE200200146A/et
Publication of EE04997B1 publication Critical patent/EE04997B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200200146A 1999-09-30 2000-09-26 Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine EE04997B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947234A DE19947234A1 (de) 1999-09-30 1999-09-30 Neue Kombination von Loteprednol und Antihistaminika
PCT/EP2000/009391 WO2001022955A2 (de) 1999-09-30 2000-09-26 Neue kombination von loteprednol und antihistaminika

Publications (2)

Publication Number Publication Date
EE200200146A true EE200200146A (et) 2003-04-15
EE04997B1 EE04997B1 (et) 2008-04-15

Family

ID=7924100

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200146A EE04997B1 (et) 1999-09-30 2000-09-26 Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine

Country Status (19)

Country Link
US (1) US7022687B1 (et)
EP (1) EP1216046B1 (et)
JP (2) JP5524438B2 (et)
AR (1) AR025923A1 (et)
AT (1) ATE241988T1 (et)
AU (1) AU7907300A (et)
BR (1) BR0014312B1 (et)
CA (1) CA2387398C (et)
CZ (1) CZ295090B6 (et)
DE (2) DE19947234A1 (et)
DK (1) DK1216046T3 (et)
EE (1) EE04997B1 (et)
ES (1) ES2199868T3 (et)
HU (1) HU229606B1 (et)
MX (1) MXPA02003174A (et)
PL (1) PL196843B1 (et)
PT (1) PT1216046E (et)
TW (1) TWI224968B (et)
WO (1) WO2001022955A2 (et)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002366567B2 (en) * 2001-12-05 2006-11-16 Alcon, Inc. Use of an H1 antagonist and a safe steroid to treat rhinitis
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
DE60333205D1 (de) 2002-08-30 2010-08-12 Nycomed Gmbh Histaminika zur behandlung von allergischer rhinitis
BR0316203A (pt) * 2002-11-12 2005-10-04 Alcon Inc Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
AU2004271744B2 (en) 2003-09-16 2010-07-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
US20060263350A1 (en) * 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
ATE441419T1 (de) * 2004-03-25 2009-09-15 Bausch & Lomb Verwendung von loteprednoletabonat zur behanldung von trockenen augen
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
DK2377557T3 (en) 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
EP2736491B1 (en) * 2011-01-04 2017-04-05 Bausch & Lomb Incorporated Bepotastine compositions
AU2013266067B2 (en) * 2012-05-25 2016-10-06 Xlear, Inc. Xylitol-based anti-mucosal compositions and related methods and compositions
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
MX2022015965A (es) * 2020-06-15 2023-03-14 Alkem Laboratories Ltd Combinacion de alcaftadina y un corticoesteroide.
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
EP0709099A3 (en) * 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
AU6392496A (en) * 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
BR9709650A (pt) * 1996-06-04 1999-08-10 Procter & Gamble Aerosol nasal contendo um esteróide intransal e um anti-histamínico
JP4453987B2 (ja) * 1997-01-16 2010-04-21 千寿製薬株式会社 点鼻用水性懸濁液

Also Published As

Publication number Publication date
EP1216046A2 (de) 2002-06-26
EP1216046B1 (de) 2003-06-04
CZ20021014A3 (cs) 2002-06-12
JP2003510275A (ja) 2003-03-18
AR025923A1 (es) 2002-12-18
HUP0202862A2 (hu) 2003-01-28
WO2001022955A2 (de) 2001-04-05
DK1216046T3 (da) 2003-09-29
PT1216046E (pt) 2003-10-31
ES2199868T3 (es) 2004-03-01
CA2387398C (en) 2009-05-12
ATE241988T1 (de) 2003-06-15
WO2001022955A3 (de) 2001-05-17
DE19947234A1 (de) 2001-04-05
PL353486A1 (en) 2003-11-17
PL196843B1 (pl) 2008-02-29
US7022687B1 (en) 2006-04-04
EE04997B1 (et) 2008-04-15
JP2012001558A (ja) 2012-01-05
HU229606B1 (en) 2014-02-28
CZ295090B6 (cs) 2005-05-18
TWI224968B (en) 2004-12-11
BR0014312A (pt) 2002-05-21
HUP0202862A3 (en) 2003-10-28
AU7907300A (en) 2001-04-30
DE50002478D1 (de) 2003-07-10
CA2387398A1 (en) 2002-03-28
JP5524438B2 (ja) 2014-06-18
MXPA02003174A (es) 2003-08-20
BR0014312B1 (pt) 2012-09-04

Similar Documents

Publication Publication Date Title
EE200200146A (et) Loteprednooli ja antihistamiinsete ainete uudne kombinatsioon
DE69831605D1 (de) Anti-östrogen- und progestin-enthaltende orale kontrazeptiva
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20022334L (no) Ny sammensetning og anvendelse
IL156565A0 (en) N-(phenylsulphonyl) glycine derivatives and their therapeutic use
EE05169B1 (et) Asendatud oksasolidinoonid ja nende kasutamine
DE69924155D1 (de) Fluoren-copolymere und daraus hergestellte vorrichtungen
NO20032753D0 (no) Forbindelse og anvendelse derav
DE50010609D1 (de) Sport-trainings-vorrichtung sowie sport-trainings-system
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DE60045459D1 (de) Wiederablösbarer Klebstoff und wiederablösbare Klebefolie
EP1162876A4 (en) REPLIABLE / DISMANTLING STRUCTURES
DE69713171D1 (de) Mundpflegezubereitung
ATE268764T1 (de) Gegenseitige prodrugs von amlopidin und atorvastatin
DE69709876D1 (de) Kieferorthopädische und parodontologische vorrichtungen
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
ITFI970019A0 (it) Attacco ortodontico e relativo procedimento di fabbricazione
ID30381A (id) Penggunaan arilalkanoilpiridazina
DE60037197D1 (de) Verwendung funktioneller oraler präparate
FI19992219L (fi) Yhdistetty difibrillaattori ja sydäntahdistin
NO20014454D0 (no) Konstruksjon og anvendelse av samme
FIU20000507U0 (fi) Clinikit DiagnoPacks ja Openkit-konsepti
FR2800257B1 (fr) Grill - infrarouge au gaz - horizontal et pivotant
ID29414A (id) Pengobatan depresi

Legal Events

Date Code Title Description
HE1A Change of address
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20170926